Banner

Ophthalmology Drugs Market 2023 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies or Drug Stores, Other Distribution Channels), By Route Of Administration (Topical, Oral, Other Route Of Administrations), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $5000.00 $3350.00 | Pages : 470 | Published : January 2023 | SKU CODE : o&s134 | | Format :


Ophthalmology Drugs Market Definition

Ophthalmology drugs market consists of sales of ophthalmology drug products by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma, inflammatory and allergic conditions of the eye, antibiotics and antivirals to treat eye infections and artificial tears or tear stimulating drugs to treat dry eye, and other drugs for treating retinal disorders and others. Some of the major ophthalmic drugs include Azopt, Betoptic, Lotemax, Restasis and Vigamox.

Ophthalmology Drugs Market Size

The global ophthalmology drugs market size reached a value of nearly $50,563.47 million in 2021, having increased at a compound annual growth rate (CAGR) of 5.99% since 2016. The market is expected to grow from $50,563.47 million in 2021 to $77,524.68 million in 2026 at a rate of 8.92%. The global ophthalmology drugs market size is then expected to grow at a CAGR of 7.65% from 2026 and reach $112,076.64 million in 2031.  

Growth in the historic period resulted from aging population, risen number of contact lens users, increased funding from public and private research organizations, increased healthcare expenditure, increase in allergy diseases (hay fever) and increase in number of treatment option. Factors that negatively affected growth in the historic period were the low healthcare access, lack of awareness and impact COVID-19.

Going forward, rise in laser surgeries, change in working lifestyle, increasing prevalence of eye-related disorders, increasing geriatric population, growing burden of the diabetes and other comorbidities, side effects of other medication and promising pipeline for dry eye disease will drive market growth. Factors that could hinder the growth of the ophthalmology drugs market in the future include long and costly drug approvals, inadequate insurance coverage and expiration of patents.

Ophthalmology Drugs Market Drivers

The key drivers of the ophthalmology drugs market include:

Change In Working Lifestyle

Changes of working lifestyles towards digitalization of the workspace and rise in sedentary jobs are forcing people to spend long hours in front of a computer screen, driving the demand for dry eye medication. Increasing cases of dry eyes from excessive time spent on electronic devices such as phones and computers has led to the development of the term “digital eye strain” or “computer vision syndrome.” It is increasingly becoming a widespread problem as more and more people are spending hours staring at computers, cellphones, and other electronic devices. In a survey published in 2021, around 227 students were surveyed. Of these respondents, 90.3% (205 students) reported experiencing the ocular and extra-ocular symptoms of digital eye strain (DES).  The continuous digitalization of the workplace is expected to be a major driver for the dry eye medications contributing to the growth of the ophthalmology drugs market.

Ophthalmology Drugs Market Restraints

The key restraints on the ophthalmology drugs market include:

Expiration Of Patents

During the forecast period, the growth of the ophthalmology drugs market is expected to be restrained by patent expiration of branded drugs. For example, the U.S. patents for Lucentis and Eylea was expired in 2020, and their European patents will expire in 2022 and 2025, respectively. Eylea also comes off patent in 2022 in China and Japan. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patent life, the company holding the patent holds exclusivity for the manufacturing and distribution of the drug. Post expiration of patent, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. The expiration of patents of branded ophthalmology drugs is expected to limit the growth of the ophthalmology drugs market.

Ophthalmology Drugs Market Trends

Major trends influencing the ophthalmology drugs market include:

Global Expansion And Acquisitions

Companies in the dry eye medication market are increasing their investments in the developing regions of South America, Africa, and Asia to capitalize on untapped market opportunities. For example, in August 2022, Alcon, an American Swiss medical company specializing in eye care products acquired Aerie Pharmaceuticals, Inc. for an undisclosed amount This transaction confirms Alcon's commitment to the ophthalmic pharmaceutical industry and is anticipated to boost the value of its diversified portfolio by boosting Alcon's current commercial expertise with broader pharmaceutical R&D capabilities. Aerie Pharmaceuticals Inc. is an USA based publicly traded, clinical-stage pharmaceutical company founded in 2005.

Single Dose Preservative Free Eye Drops

Eye drops are used for treating dry eye, eye redness, and allergic reactions. But most eye drops contain an element known as benzalkonium chloride (BAK), a preservative. This ingredient can be harmful when used regularly to treat the symptoms. Often eye drops containing preservatives are likely to cause certain eye allergies, and repeated use can impair an individual's sight. The trend of using single-dose preservative-free eye drops has increased. These eye drops are considered safe for extended use, as they are free from preservatives. For example, in July 2022, Ridge Pharma, a privately owned UK pharmaceutical company, announced the launch of Eyeaze® Carmellose 0.5% & 1% preservative free eye drops.

Opportunities And Recommendations In The Ophthalmology Drugs Market

Opportunities –The top opportunities in the ophthalmology drugs market by type will arise in the other ophthalmological drugs market, which will gain $16,427.7 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by distribution channel will arise in the retail pharmacies/ drug stores market, which will gain $12,002.1 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by mode of purchase will arise in the prescription-based drugs market, which will gain $15,620.2 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by route of administration will arise in the topical market, which will gain $16,639.5 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by drug classification will arise in the generic drugs market, which will gain $14,873.5 million of global annual sales by 2026. The ophthalmology drugs market size will gain the most in the USA at $8,734.8 million.

Recommendations –To take advantage of the opportunities, The Business Research Company recommends the companies in the ophthalmology drugs market to focus on new modes of delivery systems, focus on product innovation for dry eye treatment, focus on improvement of combination therapies, expand in emerging markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events and target cataract patients.

Ophthalmology Drugs Market Segmentation

The ophthalmology drugs market is segmented by type, by distribution channel, by route of administration, by drug classification, and by delivery model.
By Type -
The ophthalmology drugs market is segmented by type into
    • a) Antiglaucoma Drugs
    • b) Dry Eye Medication
    • c) Other Ophthalmological Drugs
The other ophthalmological drugs was the largest segment of the ophthalmology drugs market by type, accounting for $30,182.1 million or 59.7% of the total market in 2021. The dry eye medication market is expected to be the fastest-growing segment going forward at a CAGR of 10.9%.
By Distribution Channel –
The ophthalmology drugs market is segmented by distribution channel into
    • a) Hospital Pharmacies
    • b) Retail Pharmacies/ Drug Stores
    • c) Other Distribution Channels
The retail pharmacies/ drug stores market was the largest segment of the ophthalmology drugs market by distribution channel, accounting for $22,582.6 million or 44.7% of the total market in 2021. The other distribution channels market is expected to be the fastest-growing segment going forward at a CAGR of 9.1%.
By Route Of Administration –
The ophthalmology drugs market is segmented by route of administration into
    • a) Topical
    • b) Oral
    • c) Other Route Of Administration
The topical market was the largest segment of the ophthalmology drugs market by route of administration, accounting for $30,341.62 million or 60.0% of the total market in 2021. The topical market is expected to be the fastest-growing segment going forward at a CAGR of 9.1%.
By Drug Classification –
The ophthalmology drugs market is segmented by drug classification into
    • a) Branded Drugs
    • b) Generic Drugs
The branded drugs market was the largest segment of the ophthalmology drugs market by drug classification, accounting for $30,107.82 million or 59.5% of the total market in 2021. The generic drugs market is expected to be the fastest-growing segment going forward at a CAGR of 11.5%.
By Mode Of Purchase –
The ophthalmology drugs market is segmented by mode of purchase into
    • a) Over-The-Counter Drugs
    • b) Prescription-Based Drugs
The prescription-based drugs market was the largest segment of the ophthalmology drugs market by mode of purchase, accounting for $30,014.54 million or 59.4% of the total market in 2021. The over-the-counter drugs market is expected to be the fastest-growing segment going forward at a CAGR of 9.2%.
By Geography- The ophthalmology drugs market is segmented by geography into
    • o Asia Pacific
      • •  China
      • •  India
      • •  Bangladesh
      • •  Japan
      • •  Australia
      • •  Indonesia
      • •  South Korea
      • •  Hong Kong
      • •  Malaysia
      • •  New Zealand
      • •  Philippines
      • •  Singapore
      • •  Thailand
      • •  Vietnam
    • o North America
      • • USA
      • •  Canada
      • •  Mexico
      o South America
      • •  Brazil
      • •  Argentina
      • •  Chile
      • •  Colombia
      • •  Peru
      • •  Venezuela
      o Western Europe
      • •  UK
      • •  Germany
      • •  France
      • •  Austria
      • •  Belgium
      • •  Denmark
      • •  Finland
      • •  Ireland
      • •  Italy
      • •  Netherlands
      • •  Norway
      • •  Portugal
      • •  Spain
      • •  Sweden
      • •  Switzerland
      o Eastern Europe
      • •  Russia
      • •  Czech Republic
      • •  Poland
      • •  Romania
      • •  Ukraine
      o Middle East
      • •  Saudi Arabia
      • •  Israel
      • •  Iran
      • •  Turkey
      • •  UAE
      o Africa
      • •  Egypt
      • •  Nigeria
      • •  South Africa
North America was the largest region in the ophthalmology drugs market, accounting for 37.3% of the global market in 2022. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the ophthalmology drugs market will be Middle East and the South America, where growth will be at CAGRs of 11.4% and 9.9% respectively from 2021-2026.

Ophthalmology Drugs Market Competitive Landscape

Major Competitors are:

  • Regeneron Pharmaceuticals Inc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Bayer AG
  • AbbVie Inc.
  • Other Competitors Include:

  • Santen Pharmaceutical Co., Ltd.
  • Alcon
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Shanghai Pharmaceuticals
  • Santen Pharmaceutical
  • Sun Pharma
  • Johnson & Johnson
  • Otsuka Pharmaceutical Co. Ltd
  • Daiichi Sankyo
  • Lee Pharma Ltd.
  • Ji Xing Pharmaceuticals
  • Oyster Point Pharma
  • Carl Zeiss Meditec AG
  • ERC Labs
  • Vision gain
  • Medicom Health care
  • Implandata ophthalmic products GmbH
  • The Geuder Group
  • Microgen
  • Geropharm
  • Valenta
  • NovaMedica
  • Veropharm
  • Biocad
  • Roche
  • Bristol-Myers Squibb
  • Celon Pharma
  • SynBio
  • Endo International plc
  • Aurinia Pharmaceuticals Inc
  • Johnson & Johnson
  • Herzig Eye Institute
  • Thomas Eye Group
  • ReGenTree, LLC
  • Regenerx Biopharmaceuticals Inc
  • Harrow Health Inc
  • Aerie Pharmaceuticals
  • Oyster Point Pharma, Inc.,
  • Essilor International
  • Carl-Zeiss AG
  • Ellex Medical Lasers Ltd
  • Hoya Corporation
  • Abbott Medical Optics
  • Teuto Brasileiro
  • Biolab Farmaceutica
  • Cristalia
  • Dexcel Pharma
  • Orasis
  • Tarsier Pharma
  • BioLight Life Sciences Ltd
  • Essilor International
  • CribMD
  • Cipla Medpro South Africa
  • Sanofi Genzyme
  • Adcock Ingram
  • List Of Tables

      Table 1: Global Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, Split By Region
    • Table 6: Global Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Region
    • Table 7: Global Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 14: Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 15: Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 16: Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 17: Global Ophthalmology Drugs Market Value, Market Size As A Percentage Of Global GDP, 2016 – 2026
    • Table 18: Global Ophthalmology Drugs Market, Per Capita Average Ophthalmology Drugs Market Industry Expenditure, 2016 – 2026, ($)
    • Table 19: Global Ophthalmology Drugs Percentage Of GDP, By Country, 2021, %
    • Table 20: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
    • Table 21: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
    • Table 22: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 23:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 24: Asia-Pacific, Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 25: Asia-Pacific Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 26: Asia-Pacific Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 27: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 28: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 29: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 30: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 31: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 32: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 33: Asia-Pacific Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
    • Table 34: Asia-Pacific Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, By Country
    • Table 35: Asia-Pacific Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Country
    • Table 36: Asia-Pacific Per Capita Ophthalmology Drugs Expenditure, By Country, 2021, $
    • Table 37: Australia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 38: Australia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 39: Australia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 40: Australia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 41: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 42: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 43: Australia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 44: Australia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 45: Bangladesh Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 46: Bangladesh Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 47: China Population By Age Group, 2016-2026, Thousands
    • Table 48: China GDP Per Capita, 2016-2021, $
    • Table 49:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 50: China Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 51: China Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 52: China Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 53: China Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 54: China Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 55: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 56: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 57: China Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 58: China Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 59: Hong Kong Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 60: Hong Kong Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 61: India Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 62: India Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 63: India Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 64: India Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 65: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 66: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 67: India Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 68: India Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 69: Indonesia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 70: Indonesia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 71: Indonesia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 72: Indonesia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 73: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 74: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 75: Indonesia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 76: Indonesia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 77: Japan Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 78: Japan Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 79: Japan Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 80: Japan Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 81: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 82: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 83: Japan Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 84: Japan Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 85: Malaysia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 86: Malaysia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 87: New Zealand Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 88: New Zealand Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 89: Philippines Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 90: Philippines Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 91: Singapore Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 92: Singapore Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 93: South Korea Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 94: South Korea Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 95: South Korea Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 96: South Korea Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 97: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 98: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 99: South Korea Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 100: South Korea Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 101: Thailand Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 102: Thailand Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 103: Vietnam Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 104: Vietnam Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 105: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 106: Western Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 107:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 108:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 109: Western Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 110: Western Europe Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 111: Western Europe Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 112: Western Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 113: Western Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 114: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 115: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 116: Western Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 117: Western Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 118: Western Europe Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
    • Table 119: Western Europe Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, By Country
    • Table 120: Western Europe Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Country
    • Table 121: Western Europe Per Capita Ophthalmology DrugsExpenditure, By Country, 2021, $
    • Table 122: Austria Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 123: Austria Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 124: Belgium Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 125: Belgium Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 126: Denmark Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 127: Denmark Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 128: Finland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 129: Finland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 130: France Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 131: France Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 132: France Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 133: France Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 134: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 135: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 136: France Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 137: France Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 138: Germany Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 139: Germany Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 140: Germany Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 141: Germany Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 142: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 143: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 144: Germany Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 145: Germany Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 146: Ireland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 147: Ireland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 148: Italy Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 149: Italy Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 150: Netherlands Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 151: Netherlands Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 152: Norway Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 153: Norway Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 154: Portugal Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 155: Portugal Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 156: Spain Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 157: Spain Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 158: Sweden Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 159: Sweden Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 160: Switzerland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 161: Switzerland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 162: UK Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 163: UK Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 164: UK Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 165: UK Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 166: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 167: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 168: UK Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 169: UK Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 170: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 171: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 172:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 173:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 174: Eastern Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 175: Eastern Europe Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 176: Eastern Europe Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 177: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 178: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 179: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 180: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 181: Eastern Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 182: Eastern Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 183: Eastern Europe Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
    • Table 184: Eastern Europe Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, By Country
    • Table 185: Eastern Europe Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Country
    • Table 186: Eastern Europe Per Capita Ophthalmology Drugs Expenditure, By Country, 2021, $
    • Table 187: Czech Republic Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 188: Czech Republic Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 189: Poland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 190: Poland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 191: Romania Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 192: Romania Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 193: Russia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 194: Russia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 195: Russia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 196: Russia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 197: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 198: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 199: Russia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 200: Russia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 201: Ukraine Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 202: Ukraine Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 203: North America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 204: North America GDP Per Capita, By Country, 2016-2021, $
    • Table 205:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 206:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 207: North America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
    • Table 208: North America Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 209: North America Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 210: North America Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 211: North America Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 212: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 213: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 214: North America Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 215: North America Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 216: North America Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)

    List Of Figures

      Figure 1: Global Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 2: Global Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 3: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 4: Global Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
    • Figure 5: Global Ophthalmology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
    • Figure 6: Global Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 7: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 8: Global Ophthalmology Drugs Market, Segmentation By Type Of Prescription, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 9: Global Ophthalmology Drugs Market, Segmentation By Drug Variation, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 10: Asia-Pacific Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 11: Asia-Pacific Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 12: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 13: Asia- Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 14: Asia-Pacific Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • Figure 15: Asia-Pacific Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
    • Figure 16: Asia-Pacific Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • Figure 17: Australia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 18: Australia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 19: Australia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 20: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 21: China Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 22: China Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 23: China Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 24: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 25: Hong Kong Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 26: Hong Kong Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 27: India Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 28: India Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 29: India Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 30: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 31: Indonesia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 32: Indonesia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 33: Indonesia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 34: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 35: Japan Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 36: Japan Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 37: Japan Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 38: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 39: Malaysia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 40: Malaysia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 41: New Zealand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 42: New Zealand Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 43: Philippines Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 44: Philippines Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 45: Singapore Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 46: Singapore Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 47: South Korea Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 48: South Korea Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 49: South Korea Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 50: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 51: Thailand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 52: Thailand Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 53: Vietnam Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 54: Vietnam Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 55: Western Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 56: Western Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 57: Western Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 58: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 59: Western Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • Figure 60: Western Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
    • Figure 61: Western Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • Figure 62: Austria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 63: Austria Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 64: Belgium Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 65: Belgium Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 66: Denmark Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 67: Denmark Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 68: Finland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 69: Finland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 70: France Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 71: France Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 72: France Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 73: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 74: Germany Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 75: Germany Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 76: Germany Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 77: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 78: Ireland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 79: Ireland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 80: Italy Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 81: Italy Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 82: Italy Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 83: Italy Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 84: Netherlands Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 85: Netherlands Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 86: Norway Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 87: Norway Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 88: Portugal Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 89: Portugal Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 90: Spain Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 91: Spain Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 92: Spain Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 93: Spain Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 94: Sweden Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 95: Sweden Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 96: Switzerland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 97: Switzerland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 98: UK Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 99: UK Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 100: UK Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 101: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 102: Eastern Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 103: Eastern Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 104: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 105: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 106: Eastern Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • Figure 107: Eastern Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
    • Figure 108: Eastern Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • Figure 109: Czech Republic Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 110: Czech Republic Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 111: Poland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 112: Poland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 113: Romania Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 114: Romania Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 115: Russia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 116: Russia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 117: Russia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 118: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 119: North America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 120: North America Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 121: North America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 122: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 123: North America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • Figure 124: North America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
    • Figure 125: North America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • Figure 126: Canada Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 127: Canada Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 128: Mexico Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 129: Mexico Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 130: USA Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 131: USA Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 132: USA Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 133: USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 134: South America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 135: South America Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 136: South America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 137: South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 138: South America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • Figure 139: South America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
    • Figure 140: South America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • Figure 141: Argentina Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 142: Argentina Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 143: Chile Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 144: Chile Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 145: Colombia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 146: Colombia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 147: Brazil Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 148: Brazil Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 149: Brazil Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 150: Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 151: Peru Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 152: Peru Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 153: Venezuela Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 154: Venezuela Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 155: Middle East Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 156: Middle East Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 157: Middle East Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 158: Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 159: Middle East Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • Figure 160: Middle East Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
    • Figure 161: Middle East Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • Figure 162: Israel Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 163: Israel Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 164: Saudi Arabia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 165: Saudi Arabia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 166: Turkey Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 167: Turkey Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 168: UAE Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 169: UAE Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 170: Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 171: Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 172: Africa Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 173: Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
    • Figure 174: Africa Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • Figure 175: Africa Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
    • Figure 176: Africa Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • Figure 177: Egypt Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 178: Egypt Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 179: Nigeria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 180: Nigeria Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 181: South Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
    • Figure 182: South Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
    • Figure 183: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
    • Figure 184: Allergan Plc.– Financial Performance, 2015 - 2019, $ Billion
    • Figure 185: Santen Pharmaceutical Co Ltd.– Financial Performance, 2014-2018, $ Billion
    • Figure 186: Global Pharmaceutical Drugs Market, 2019, Split By Segment
    • Figure 187: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Segment
    • Figure 188: Global Pharmaceutical Drugs Market, 2019, Split By Region
    • Figure 189: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report